Author

Robert F. Berman

University of California, DavisORCID 0000-0001-8530-3147Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:rat· 1

Frequent Co-Authors

Abby L. OlseniD· 1 shared Ahmed F. Mohamed· 1 shared Albee MessingiD· 1 shared Berit E. PowersiD· 1 shared Curt MazuriD· 1 shared Frank RigoiD· 1 shared Gemma BachmanniD· 1 shared Katerina L. DagueiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Abby L. OlsenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Antisense therapy in a new rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment.

Tracy L. Hagemann, Berit E. Powers, Ni‐Hsuan Lin, Ahmed F. Mohamed, Katerina L. Dague, Seth C. Hannah, Gemma Bachmann, Curt Mazur, Frank Rigo, Abby L. Olsen, Mel Β. Feany, Ming‐Der Perng, Robert F. Berman, Albee Messing

This paper introduces a new rat model of Alexander disease that exhibits key pathological features and motor impairment, demonstrating that antisense oligonucleotide therapy can reverse GFAP pathology and white matter deficits.

Science Translational Medicine · Nov 17, 2021Peer-reviewedNeuroscience